Testing, Prevention and Care IDU in Chicago, 2009

Similar documents
Nikhil Prachand, MPH Britt Skaathun

The Heterosexual HIV Epidemic in Chicago: Insights into the Social Determinants of HIV

National HIV Behavioral Surveillance Portland, Oregon

Supplement to HIV and AIDS Surveillance (SHAS)

Additional North Carolina Projects

Ryan White Program Demographic Data Fiscal Year 25

State of Florida Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need, CY

Responding to HIV/AIDS in Illinois Remarks to the Adequate Health Care Task Force

Medical Case Management Training Series Module 1. Anissa Ray & Vadim Kogan

Syringe Exchange Research Update Harm Reduction Coalition August 2008

Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles

Co-occurring Psychosocial Health Disparities and ARV Medication Adherence among Indigent HIV-positive Patients who Use Drugs

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

National HIV Behavioral Surveillance Report

City of Chicago Department of Public Health Pre-Announcement of the HIV Prevention Request for Proposals (RFP)

Building and enhancing capacity for HCV prevention; BC case scenario

Epidemiologic Trends in HIV in Illinois. Prepared by Cheryl Ward for the 24 th Annual Illinois HIV/STD Conference

Enhanced Housing Placement Assistance (EHPA): Baseline Characteristics of Homeless PLWHA in New York City

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Strategies of drug users to avoid infection with hepatitis C

Yale University, New Haven, CT, USA

Update Report # 45. Patterns of Sexual Behaviors and Sexual Risk among HIV Positive People in New York City

HIV risk associated with injection drug use in Houston, Texas 2009: A Latent Class Analysis

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

HIV Prevalence and Unrecognized HIV Infection Among Men Who Have Sex With Men: Chicago HIV Behavioral Surveillance, 2008

INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial.

Safeworks and Harm Reduction

HIV Testing Survey, 2002

CitiWide Harm Reduction

As a result of this training, participants will be able to:

Jefferson County Syringe Exchange Program (SEP) Annual Report 2017

Needs Assessment of People Living with HIV in the Boston EMA. Needs Resources and Allocations Committee March 10 th, 2016

BALTIMORE COUNTY HIV/AIDS EPIDEMIOLOGICAL PROFILE Fourth Quarter Data reported throuh December 31, 2007

Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City

HepTalk Listserv Archive August 2005

SPEEDBALLS INJECTING HEROIN & CRACK (OR COCAINE)

As a result of this training, participants will be able to:

Detection of Hepatitis B and C in Primary Care

Patient Care Planning Group April 3, 2014

Leveraging data to monitor the rise of cocaine and methamphetamine in Philadelphia

Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians

American Men s Internet Survey (AMIS)

PrEP Home Checklist v1.0

Prevention of and Immunisation against Hepatitis B and C

Hartford Transitional Grant Area (TGA) Quality Management Plan

Saskatchewan HIV Strategy: Social Network Approach

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives

Signs of success latest national NESI data?

PrEP Active Referrals at the Chicago Dept. of Public Health: past, present, and future. Ramona Bhatia, MD MS Supervising Physician HIV/STI 9/29/16

Getting to Zero in California: Integration of HIV Prevention and Surveillance

Glossary of Acronyms. AIDS - Acquired Immunodeficiency Syndrome. CDC - Centers for Disease Control and Prevention. DHS - Department of Health Services

Surveillance for Hepatitis C Among Youth in NYC. Kate Prussing Harlem Hep C Task Force Meeting, June 4, 2014

Hepatitis C Best Practice Guidelines For Local Health Departments

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences

MOBILE OUTREACH. A guide to help plan and implement a Mobile Outreach Vehicle (MOV)-based risk reduction intervention program.

who use drugs in order to assist them in reducing harm while in the cycle of addiction

Understanding HIV Risk and Prevention Behaviors Among Heterosexuals at Increased Risk for HIV Infection

EXCHANGE SEX AND SUBSTANCE USE WITHIN A SAMPLE OF HOMELESS YOUTH IN LOS ANGELES. What is exchange sex? Who are homeless youth?

Epidemiology of Hepatitis C Boston, 2015 Craig Regis, MPH Infectious Disease Bureau Boston Public Health Commission

HIV/AIDS in Massachusetts

Notes Detection of Hepatitis B and C in Primary Care

Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings

HIV/AIDS Surveillance and Reporting Requirements

Prevention of and Immunisation against Hepatitis B and C

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Campus-Community Strategies in Substance Use/Misuse and HIV Prevention Frances M. Harding Director SAMHSA s Center for Substance Abuse Prevention

Status of the HIV/AIDS Epidemic San Francisco

Introduction. Relationships. Condoms. HIV Testing. DC HIV Behavior Study #1. Here is what we learned:

Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros

Targeted Outreach & Other Strategies for Increasing HCV Testing

Hepatitis C Virus Infection Among Young Drug Users What Can Viral Hepatitis Coordinators and Health Departments Do?

Project SUCCEED Overview. Project Scaling-Up Co-Infection Care to End Ethnic Disparities Brooklyn Hep C Task Force February 6, 2018

Heroin. What is heroin?

High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing?

Bridging Sexual Boundaries: Men Who Have Sex with Men and Women in a Street-Based Sample in Los Angeles

ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece

State of Alabama HIV Surveillance 2014 Annual Report

State of Alabama HIV Surveillance 2013 Annual Report Finalized

BC Enhanced Hepatitis Strain Surveillance Project Hepatitis B. Acute HBV Questionnaire

Laura Kann PhD, Emily O Malley Olsen MSPH, Tim McManus MS, and Stephanie Zaza MD

The MAX Clinic: A Structural Healthcare Systems Intervention Designed to Engage the Hardest-to- Reach Persons Living with HIV/AIDS

Minneapolis Department of Health and Family Support HIV Surveillance

North Dakota Native American HIV/AIDS Needs Assessment

Florida s HIV Testing Efforts

PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS

Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies

Albuquerque Health Care for the Homeless (AHCH)

BALTIMORE CITY HIV/AIDS EPIDEMIOLOGICAL PROFILE Second Quarter Data reported through June 30, 2008

Public drug policies Catalonia

Prevention of and Immunisation against Hepatitis B and C

Harm reduction among drug users in Spain

PrEP 201: Beyond the Basics

Hepatitis C Screening, Retesting, and Treatment Discussion among HIV+ Persons in Care, 2011

Carol Strike, PhD & Tara Marie Watson, PhD and the Working Group on Best Practice for Harm Reduction Programs in Canada

Fax completed form to: (204) Further inquiries: your CD Coordinator

Transcription:

HIV/HCV Risk Behaviors, Testing, Prevention and Care IDU in Chicago, 2009 Nik Prachand Britt Livak HIV Behavioral Surveillance IDU2 Cycle Surveillance, Epidemiology and Research Division of STI/HIV/AIDS Chicago Department of Public Health

HIV Behavioral Surveillance Ongoing g gnational system to monitor: HIV/STD risk behaviors HIV testing behaviors Exposure to HIV prevention Conducted in 21 cities in U.S. Three primary populations (MSM, IDU, HET) Annual surveys repeated in 3-year cycles IDU1 2005 IDU2-2009

HIV (not AIDS) 2000 thru 2008 by Mode of Transmission 800 700 600 iagnoses Number of HIV Di 500 400 300 200 100 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 Year of Diagnosis MSM IDU MSM/IDU Het Chicago Department of Public Health STD/HIV/AIDS Division Surveillance, Epidemiology and Research Section

HIV (not AIDS) 2000 thru 2008 by Mode of Transmission 70% 60% Percent of HIV Diagnoses 50% 40% 30% 20% 10% 0% 2000 2001 2002 2003 2004 2005 2006 2007 2008 Year of Diagnosis MSM IDU MSM/IDU Het Chicago Department of Public Health STD/HIV/AIDS Division Surveillance, Epidemiology and Research Section

Methods Recruitment and Data Collection: August 12, 2009 November 24, 2009 Conducted 25-minute Survey with eligible IDUs Tested for HIV and Hepatitis C, and STARHS @ 4 neighborhood-based locations citywide Different location each day (Mon-Thurs)

Respondent-Driven Sampling Form of Chain Referral First Link on the Chain AS Seed Seed completes interview and is given 3 coupons Seed gives coupons to other IDUs he or she knows After other IDUs complete interview they are each given 3 coupons And so on and so on

Incentives RDS uses dual incentives Participants were given $25 for completing the survey, $25 to compensate for time taken for HIV/HCV testing, and $10 for each eligible peer that they recruited Participants were restricted to 3 coupons

Selecting Seeds Seeds are IDUs that we already know Dynamic individuals Knowledgeable ld about the IDU situation i in the community Personally know other IDUs Many IDUs within the community come to them for information i

Selecting Seeds 9 Initial Seeds were diverse by: Race/Ethnicity (4 AA, 3 W, 2 H) Gender (5 M / 4 F) Geography Type of Drug Used (Heroin / Cocaine) Recruited through CBOs/NX/Methadone

Interview Locations CDPH South Austin Clinic (Madison/Keeler) COIP Englewood (63 rd /Ashland) CDPH Lakeview Clinic (Diversey/Clark) CALOR Storefront (Grand/Pulaski)

Results

5f full-time staff 1 van 14 weeks 679 persons screened 545 IDU

Gender

Race/Ethnicity (n=545) NH White (n=129) 24% Latino (n=180) 33% Other (n=3) 1% NH Black (n=233) 43%

Age (median = 44 years; range (18 79)) 55+ (n=85) 16% 18-24 (n=28) 5% 25-34 (n=111) 20% 45-54 (n=173) 32% 35-44 (n=148) 27%

Socioeconomic Characteristics Income in last year: 50% < $10,000 5% >$50,000 45% reported being homeless in the past year 58% currently homeless (21% in IDU1) 38% less than high school education 70% currently have no health insurance 30% have not been to a doctor in past 12 months

Drug Use Powdered heroin primary drug (98%) 90% daily injectors (any drug) 40% reported speedball use in past year (7% daily) Median Age at first injection: 21 (range: 9 49) Non-injecting drug use was less common than 2005 20% reported using crack regularly (once a week+) 33% reported snorting or smoking heroin 72% reported some drug treatment (in lifetime)

Sharing Behavior Used A Needle That May Have Been Used By Someone Else in the Past 12 Months (n=545) 5% 1% 0% Never 18% Rarely Half the time Most of the time Always 76% 63% (2005)

Shared A Needle in the Past 12 Months (n=545) 100% 80% 60% 40% 20% 0% 23% 26% Male Female

Shared A Needle in the Past 12 Months (n=545) 100% 80% 60% 40% 20% 0% 24% 24% 16% NH White NH Black Hispanic

Shared A Needle in the Past 12 Months (n=545) 100% 80% 60% 57% 52% (2005) 45% (2005) 40% 20% 30% 30% 17% 9% 0% 18-24 25-34 35-44 45-54 55+

Shared Cottons, Cooker, or Water After Someone Else's Needle Touched It in the Past 12 Months (n=545) 16% (2005) 14% 4% 2% Never Rarely Half the time 50% Most of the time Always 31% 51% (2005)

Shared Cottons, Cookers, or Water in the Past 12 months (n=545) 100% 80% 60% 51% 50% 40% 20% 0% Male Female

Shared Cottons, Cookers, or Water in the Past 12 months (n=545) 100% 80% 60% 40% 20% 60% 48% 48% 0% NH White NH Black Hispanic

Shared Cottons, Cookers, or Water in the Past 12 months (n=545) 100% 80% 79% 64% (2005) 60% 40% 54% 49% 48% 44% 20% 0% 18-24 25-34 35-44 45-54 55+

Sources of Needles From: Doctor s Office: 8% Bought from Pharmacy 44% 32% (2005) Dealer, street 17% Friend, acquaintance, sex partner 52% Needle Exchange 69%

Acquired Needles from a Local Needle Exchange (n=545) 100% 80% 69% 70% 60% 40% 20% 0% Male Female

Acquired Needles from a Local Needle Exchange (n=545) 100% 80% 60% 40% 20% 82% (2005) 68% 65% 76% 0% NH White NH Black Hispanic

100% 80% 60% 40% 20% 79% Acquired Needles from a Local Needle Exchange (n=545) 74% (2005) 61% 67% 72% 75% 0% 18-24 25-34 35-44 45-54 55+

Prevention Utilization 55% have received free condoms in past year 66% reported receiving free sterile needles in past year 92% received them from needle exchange program 63% received free injection supplies 76% (2005) 92% were from needle exchange 7% free needles from other HIV-focused organizations 30% (2005)

Hepatitis C Of total sample: 545 IDU Over half (65%) have been tested for HCV 45% (2005) 27% tested in the past year 64% of those tested reported being diagnosed with HCV 8% among IDU under 30 years of age 84% have received NO treatment t t for HCV 72% have NOT been vaccinated for Hepatitis A & B

Hepatitis C Prevalence (from study testing) 59% (n=203) tested HCV-positive 66% among NH Black IDU 38% among NH White IDU 64% among Hispanic IDU 75% of HCV+ are 40 years or older 59% of HCV+ unaware of their infection

Characteristics of IDU with Unrecognized HCV Infection 80% 70% 60% 50% 40% 30% 20% 10% 0% <= HS Grad (n=143) 50,000+ (n=5) 20,000-49,999 (n=35) 0-19,999 (n=163) Latino (n=69) NH White (n=29) NH Black (n=105) Female (n= =45) Male (n=157) Some College + (n=60) Unrecognized HCV Infection Race/Ethnicity Annual Income Highest Level of Education Gender

HIV Testing and Treatment

HIV Testing 90% have been tested for HIV (lifetime) 46% not tested in the past year 24% (2005) Believe they are low risk (39%) Afraid to find out (33%) Most often reported location of most recent HIV test: Needle Exchange 20% Public Health Clinic i 17% Hospital/ED 16% Jail 15%

HIV Prevalence 5.5% (n=29) tested HIV-positive 5.8% among NH Black IDU 4.7% among NH White IDU 5.7% among Latino IDU 72% of HIV+ are 40 years or older 48% of HIV+ unaware of their infection 29% of unaware reported no lifetime HIV test

80% 70% 60% 50% 40% 30% 20% 10% 0% Characteristics of IDU with Unrecognized HIV Infection 20,000-49,999 (n=5) 0-19,999 (n=23) Latino (n=7) NH White <= HS Grad (n=16) 50,000+ (n=1) NH Black (n=13) Female (n=4) Male (n=25) Some College + (n=13) (n=1) Unrecognized HIV Infection Race/Ethnicity Annual Income Highest Level of Education Gender

HIV Positive IDU 93% have seen a PCP for HIV treatment 57% currently taking HIV antiretrovirals (ARV) 66% not taking ARVs due to adequate CD4 count & viral load. 83% (2005)

Conclusions Sharing: Needles may have decreased among older IDUs Needles/Works - increased slightly among young IDUs Pharmacy may be growing as a source of new needles May be impacting access to clean works, testing at NX HIV and HCV treatment options need to be expanded Rates of unrecognized HIV infection significantly higher than national estimates Must work to preserve gains!!